Incyte (INCY) Analyst Not Worried About PML News
Tweet Send to a Friend
This morning shares of Incyte (NASDAQ: INCY) declined on news that a patient taking Jakafi developed PML. The patent had ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE